HCC
HOLX

Hirtle Callaghan & Co’s Hologic HOLX Stock Holding History

Hirtle Callaghan & Co’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-2,500
Closed -$52K – 631
2013
Q3 		$52K Buy
+2,500
New +$53.2K 0.01% 335

Other funds holding HOLX

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RI
Relational Investors San Diego, California $840M AUM 0.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Hirtle Callaghan & Co's HOLX Position: Q4 2013 in Review

Hirtle Callaghan & Co sold out of Hologic (HOLX) in Q4 2013, closing a stake of 2,500 shares — an estimated $52K sold.

Hirtle Callaghan & Co first reported a position in HOLX in Q3 2013 and held it in 1 quarter. The position peaked at $52K in Q3 2013. 326 funds tracked by Wall St. Rank hold HOLX as of Q4 2013.

  • Hirtle Callaghan & Co reported no remaining Hologic position as of Q4 2013 after selling out during the quarter.
  • Hirtle Callaghan & Co sold 2,500 Hologic shares in Q4 2013, an estimated $52K.
  • Hirtle Callaghan & Co first reported a position in Hologic in Q3 2013 and held it in 1 quarter.
  • Hirtle Callaghan & Co's Hologic position peaked at $52K in Q3 2013.
  • 326 funds tracked by Wall St. Rank held Hologic as of Q4 2013.

Based on Hirtle Callaghan & Co's 13F filing for Q4 2013, filed 29 Jan 2014.